E-ISSN 2577-5669
 

Original Research 


Natural drug leads as novel DPP-IV inhibitors targeting the management of type 2 diabetes mellitus

Keddagoda Gamage Piyumi Wasana, Anoja Priyadarshani Attanayake, Kamani Ayoma Perera Wijewardana Jayatilaka & Thilak Priyantha Weerarathna.

Abstract
Aim: Number of type 2 diabetes mellitus (T2DM) patients using incretin based therapeutics has significantly increased in past few years. The development of novel incretin based therapeutics from natural sources has become an interesting area of drug discovery. The current review emphasizes the plants having DPP-IV inhibitory activity that can be used in the development of novel anti-diabetic agents.
Methods: The relevant literature was collected form data sources as PubMed, Web of Science and Google Scholar. The references of articles were also examined to obtain further information.
Results: To date, number of plants were documented for itsí antidiabetic potential through DPP-IV inhibitory activity either in vivo or in vitro. The compounds which exert potent DPP-IV inhibitory action have been identified and their structures have been deduced in some research findings. The DPP-IV inhibitory activity has been compared with positive controls in most of the studies.
Conclusion: The present review reports on natural DPP-IV inhibitors through the assessment of plant profile used in the management of DM and highlights a new pathway for the researches to develop novel molecules from herbal sources with DPP-IV inhibitory activity.

Key words: Diabetes mellitus, incretin, incretin based therapies, dipeptidyl peptidase-IV, plant profile


 
ARTICLE TOOLS
Abstract
PDF Fulltext
How to cite this articleHow to cite this article
Citation Tools
Related Records
 Articles by Keddagoda Gamage Piyumi Wasana
Articles by Anoja Priyadarshani Attanayake
Articles by Kamani Ayoma Perera Wijewardana Jayatilaka & Thilak Priyantha Weerarathna
on Google
on Google Scholar


How to Cite this Article
Pubmed Style

Keddagoda Gamage Piyumi Wasana, Anoja Priyadarshani Attanayake, Kamani Ayoma Perera Wijewardana Jayatilaka and Thilak Priyantha Weerarathna. Natural drug leads as novel DPP-IV inhibitors targeting the management of type 2 diabetes mellitus. J Complement Med Res. 2020; 11(1): 43-53. doi:10.5455/jcmr.2020.11.01.06


Web Style

Keddagoda Gamage Piyumi Wasana, Anoja Priyadarshani Attanayake, Kamani Ayoma Perera Wijewardana Jayatilaka and Thilak Priyantha Weerarathna. Natural drug leads as novel DPP-IV inhibitors targeting the management of type 2 diabetes mellitus. http://www.jocmr.com/?mno=115987 [Access: June 17, 2020]. doi:10.5455/jcmr.2020.11.01.06


AMA (American Medical Association) Style

Keddagoda Gamage Piyumi Wasana, Anoja Priyadarshani Attanayake, Kamani Ayoma Perera Wijewardana Jayatilaka and Thilak Priyantha Weerarathna. Natural drug leads as novel DPP-IV inhibitors targeting the management of type 2 diabetes mellitus. J Complement Med Res. 2020; 11(1): 43-53. doi:10.5455/jcmr.2020.11.01.06



Vancouver/ICMJE Style

Keddagoda Gamage Piyumi Wasana, Anoja Priyadarshani Attanayake, Kamani Ayoma Perera Wijewardana Jayatilaka and Thilak Priyantha Weerarathna. Natural drug leads as novel DPP-IV inhibitors targeting the management of type 2 diabetes mellitus. J Complement Med Res. (2020), [cited June 17, 2020]; 11(1): 43-53. doi:10.5455/jcmr.2020.11.01.06



Harvard Style

Keddagoda Gamage Piyumi Wasana, Anoja Priyadarshani Attanayake, Kamani Ayoma Perera Wijewardana Jayatilaka and Thilak Priyantha Weerarathna (2020) Natural drug leads as novel DPP-IV inhibitors targeting the management of type 2 diabetes mellitus. J Complement Med Res, 11 (1), 43-53. doi:10.5455/jcmr.2020.11.01.06



Turabian Style

Keddagoda Gamage Piyumi Wasana, Anoja Priyadarshani Attanayake, Kamani Ayoma Perera Wijewardana Jayatilaka and Thilak Priyantha Weerarathna. 2020. Natural drug leads as novel DPP-IV inhibitors targeting the management of type 2 diabetes mellitus. Journal of Complementary Medicine Research, 11 (1), 43-53. doi:10.5455/jcmr.2020.11.01.06



Chicago Style

Keddagoda Gamage Piyumi Wasana, Anoja Priyadarshani Attanayake, Kamani Ayoma Perera Wijewardana Jayatilaka and Thilak Priyantha Weerarathna. "Natural drug leads as novel DPP-IV inhibitors targeting the management of type 2 diabetes mellitus." Journal of Complementary Medicine Research 11 (2020), 43-53. doi:10.5455/jcmr.2020.11.01.06



MLA (The Modern Language Association) Style

Keddagoda Gamage Piyumi Wasana, Anoja Priyadarshani Attanayake, Kamani Ayoma Perera Wijewardana Jayatilaka and Thilak Priyantha Weerarathna. "Natural drug leads as novel DPP-IV inhibitors targeting the management of type 2 diabetes mellitus." Journal of Complementary Medicine Research 11.1 (2020), 43-53. Print. doi:10.5455/jcmr.2020.11.01.06



APA (American Psychological Association) Style

Keddagoda Gamage Piyumi Wasana, Anoja Priyadarshani Attanayake, Kamani Ayoma Perera Wijewardana Jayatilaka and Thilak Priyantha Weerarathna (2020) Natural drug leads as novel DPP-IV inhibitors targeting the management of type 2 diabetes mellitus. Journal of Complementary Medicine Research, 11 (1), 43-53. doi:10.5455/jcmr.2020.11.01.06